| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.97▼ | 0.97▼ | 0.97▼ | 0.99▼ | 1.00▼ |
| MA10 | 0.98▼ | 0.98▼ | 0.98▼ | 1.00▼ | 1.00▼ |
| MA20 | 0.98▼ | 0.98▼ | 0.99▼ | 1.00▼ | 1.00▼ |
| MA50 | 1.00▼ | 1.00▼ | 1.00▼ | 1.00▼ | 1.04▼ |
| MA100 | 0.98▼ | 0.99▼ | 0.99▼ | 1.00▼ | 1.20▼ |
| MA200 | 1.01▼ | 1.04▼ | 1.03▼ | 0.99▼ | 1.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.002▼ | -0.002▼ | -0.004▼ | 0.000▲ |
| RSI | 37.430▼ | 39.276▼ | 40.404▼ | 43.027▼ | 45.623▼ |
| STOCH | 0.000▼ | 0.000▼ | 27.200 | 24.377 | 41.387 |
| WILL %R | -100.000▼ | -100.000▼ | -83.278▼ | -94.333▼ | -77.302▼ |
| CCI | -162.101▼ | -159.175▼ | -140.045▼ | -151.146▼ | -51.077 |
|
Tuesday, December 04, 2018 05:09 AM
Iluvien is the company’s lead development product and is licensed to Alimera Sciences (NASDAQ:ALIM), which uses EyePoint’s third-generation Durasert technology. EyePoint has three FDA-approved ...
|
|
Saturday, December 01, 2018 10:52 PM
Alimera Sciences Inc (NASDAQ:ALIM) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 412,993 shares, a decl...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/12/18 | 0.985 | 0.985 | 0.9651 | 0.9651 | 34,173 |
| 13/12/18 | 1.01 | 1.01 | 0.985 | 1.00 | 10,630 |
| 12/12/18 | 1.01 | 1.01 | 0.96 | 0.98 | 26,114 |
| 11/12/18 | 0.97 | 1.02 | 0.97 | 0.9801 | 240,950 |
| 10/12/18 | 1.05 | 1.05 | 0.99 | 1.00 | 16,435 |
| 07/12/18 | 0.966 | 1.04 | 0.966 | 0.98 | 21,333 |
| 06/12/18 | 0.9847 | 1.00 | 0.966 | 0.995 | 118,410 |
| 04/12/18 | 1.03 | 1.04 | 1.00 | 1.01 | 215,862 |
| 03/12/18 | 1.04 | 1.05 | 1.00 | 1.03 | 25,789 |
| 30/11/18 | 0.981 | 1.04 | 0.97 | 1.02 | 66,164 |
|
|
||||
|
|
||||
|
|
||||
|
|